Taglietti Marco
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Taglietti Marco. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SCYX | Chief Executive Officer | Purchase | 75,000 | $3.00 | $225,000 | Apr 26, 2022 |
| SCYX | Chief Executive Officer | Award / Grant | 87,200 | — | — | Feb 4, 2022 |
| SCYX | Chief Executive Officer | Purchase | 40,000 | $6.25 | $250,000 | Dec 21, 2020 |
| DCTH | C | 6,000 | — | — | May 8, 2020 | |
| SCYX | Chief Executive Officer | Purchase | 166,667 | $0.90 | $150,000 | Dec 12, 2019 |
| SCYX | Chief Executive Officer | Purchase | 500 | $1.11 | $555 | Aug 21, 2019 |
| SCYX | Chief Executive Officer | Purchase | 10,015 | $1.01 | $10,115 | Aug 15, 2019 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $1.63 | $40,750 | Apr 17, 2019 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $0.69 | $17,250 | Jan 10, 2019 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $0.46 | $11,500 | Dec 31, 2018 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $1.29 | $32,250 | Aug 23, 2018 |
| SCYX | Chief Executive Officer | Purchase | 100,000 | $1.69 | $169,000 | Mar 8, 2018 |
| SCYX | Chief Executive Officer | Purchase | 10,000 | $2.23 | $22,300 | Sep 22, 2017 |
| SCYX | Chief Executive Officer | Purchase | 7 | $1.61 | $11 | Aug 23, 2017 |
| SCYX | Chief Executive Officer | Purchase | 10,000 | $1.61 | $16,100 | Aug 15, 2017 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $1.69 | $42,250 | May 12, 2017 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $3.30 | $82,500 | Dec 21, 2016 |
| SCYX | Chief Executive Officer | Purchase | 100,000 | $2.39 | $239,000 | Jun 24, 2016 |
| SCYX | Chief Executive Officer | Purchase | 246 | $3.20 | $787 | May 25, 2016 |
| SCYX | Chief Executive Officer | Purchase | 5,754 | $3.26 | $18,758 | May 25, 2016 |
| SCYX | Chief Executive Officer | Purchase | 5,500 | $3.37 | $18,535 | May 24, 2016 |
| SCYX | Chief Executive Officer | Purchase | 3,000 | $3.15 | $9,450 | May 20, 2016 |
| SCYX | Chief Executive Officer | Purchase | 6,000 | $3.07 | $18,420 | May 19, 2016 |
| SCYX | Chief Executive Officer | Purchase | 15,000 | $6.79 | $101,850 | Nov 24, 2015 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $7.82 | $195,500 | Aug 31, 2015 |
| SCYX | Chief Executive Officer | Purchase | 400 | $7.15 | $2,860 | Aug 27, 2015 |
| SCYX | Chief Executive Officer | Purchase | 25,000 | $6.98 | $174,500 | Aug 25, 2015 |
| DCTH | Purchase | 50,000 | $0.52 | $26,000 | Jul 28, 2015 | |
| DCTH | Award / Grant | 20,000 | — | — | Jun 10, 2015 | |
| 0000038074 | See Remarks | Disposition | 31,334 | — | — | Jul 1, 2014 |
| 0000038074 | EVP-Drug Dev & Ch.Medical Off. | Tax Withholding | 3,016 | $92.23 | $278,166 | May 15, 2014 |
| 0000038074 | EVP-Drug Dev & Ch.Medical Off. | Tax Withholding | 5,703 | $56.34 | $321,307 | Dec 7, 2013 |
| 0000038074 | EVP-Drug Dev & Ch.Medical Off. | Tax Withholding | 2,348 | $55.87 | $131,183 | Dec 5, 2013 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Award / Grant | 15,920 | — | — | May 21, 2013 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Tax Withholding | 1,058 | $38.88 | $41,135 | May 15, 2013 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Tax Withholding | 4,635 | $35.78 | $165,840 | Dec 8, 2012 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Tax Withholding | 4,090 | $35.83 | $146,545 | Dec 6, 2012 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Tax Withholding | 2,292 | $35.87 | $82,214 | Dec 5, 2012 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Sale | 1,200 | $35.51 | $42,612 | Sep 6, 2012 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Award / Grant | 8,600 | — | — | May 7, 2012 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Tax Withholding | 3,477 | $29.87 | $103,858 | Dec 8, 2011 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Tax Withholding | 3,830 | $30.13 | $115,398 | Dec 7, 2011 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Tax Withholding | 4,658 | $30.09 | $140,159 | Dec 6, 2011 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Award / Grant | 19,100 | — | — | Dec 5, 2011 |
| 0000038074 | Sr.VP-R&D & Chief Medical Off. | Sale | 3,000 | $34.72 | $104,160 | May 23, 2011 |
| 0000038074 | Exec. VP-Chief Medical Officer | Tax Withholding | 2,727 | $32.12 | $87,591 | Dec 8, 2010 |
| 0000038074 | Exec. VP-Chief Medical Officer | Tax Withholding | 3,636 | $32.20 | $117,079 | Dec 7, 2010 |
| 0000038074 | Exec. VP-Chief Medical Officer | Award / Grant | 45,000 | — | — | Dec 6, 2010 |
| 0000038074 | Exec. VP-Chief Medical Officer | Sale | 600 | $32.72 | $19,632 | Nov 18, 2010 |
| 0000038074 | Exec. VP-Chief Medical Officer | Tax Withholding | 2,884 | $30.77 | $88,741 | Dec 8, 2009 |